Baxter Investors Face Dec. 15 Deadline To Seek Lead Role In Securities Suit Over Novum IQ Pump
Under the PSLRA, the court will choose a lead investor based on financial interest in the case.
Overview
- The federal securities class action covers Baxter share purchases from February 23, 2022 through July 30, 2025, with a December 15, 2025 deadline to move for lead plaintiff.
- Plaintiffs allege the Novum IQ Large Volume Pump had systemic defects that caused underinfusion, overinfusion, and non‑delivery of fluids.
- A July 14, 2025 customer letter disclosed 79 reports of serious injury and two patient deaths linked to the device.
- Baxter warned customers in April and July 2025 and on July 31, 2025 announced a voluntary pause of Novum IQ pump shipments and installations.
- The July 31 announcement was followed by a roughly 22.4% share-price drop to $21.76, and multiple firms including Rosen, Kirby McInerney, Faruqi & Faruqi, and Howard G. Smith are soliciting lead-plaintiff candidates.